Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Juvenile Rheumatoid Arthritis (JRA): early-phase trial registry

2 of 2 indexed Juvenile Rheumatoid Arthritis (JRA) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Juvenile Rheumatoid Arthritis (JRA): 2 US clinical trials tracked, 2 recruiting.

Juvenile Rheumatoid Arthritis (JRA) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Brain Inflammation Collaborative, running 1 of these trials.

Enrollment posture brief

Registry condition juvenile-rheumatoid-arthritis-jra

OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Juvenile Rheumatoid Arth (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Juvenile Rheumatoid Arthritis (JRA)

Juvenile Rheumatoid Arthritis (JRA) lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Juvenile Rheumatoid Arthritis (JRA) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Juvenile Rheumatoid Arthritis (JRA) is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Juvenile Rheumatoid Arthritis (JRA) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Thiotepa Drug
1 trials
Hydroxyurea Drug
1 trials
Alemtuzumab Drug
1 trials
Melphalan Drug
1 trials
Fludarabine Drug
1 trials

US sites by state

Facility locations filed on Juvenile Rheumatoid Arthritis (JRA) trials. A trial with sites in several states counts in each.

Wisconsin 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Juvenile Rheumatoid Arthritis (JRA) page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Juvenile Rheumatoid Arthritis (JRA) condition card totals 2 registered trials; most-linked intervention Thiotepa; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.